AI Platform for Structure-Guided Molecular Discovery

Design nanobodies, mini-binders and small molecules using structural biology and AI.

Explore Platform Request Demo

A Platform for AI-Driven Molecular Engineering

CycloGen AI integrates protein structure prediction, molecular docking, binder engineering and ligand design into a unified discovery platform.

Researchers can explore molecular space, predict protein structures and design therapeutic molecules using advanced AI models — all without writing a single line of code.

Molecular Design Modules

Comprehensive AI-powered tools for every stage of therapeutic discovery

Nanobody Design

Nanobody Design

Engineer compact single-domain antibodies with enhanced stability and unique binding capabilities.

Mini Binder Design

Mini Binder Design

Engineer compact, high-affinity binders for diagnostic and therapeutic applications.

Structure Prediction

Structure Prediction

Predict protein structures with state-of-the-art deep learning models.

Target Discovery

Target Discovery

Identify and validate novel therapeutic targets through AI-powered analysis.

Mutation Analysis

Mutation Analysis

Analyze mutation impact on protein function, stability and drug resistance.

Ligand Discovery

Ligand Discovery

Discover and optimize small molecule ligands using AI-driven docking and scoring.

Advancing Therapeutic Discovery

CycloGen AI accelerates the discovery pipeline from target identification to candidate molecule design.

The platform combines deep learning, structural biology and computational chemistry to enable faster molecular discovery with higher success rates.

Platform Capabilities

Integrated tools powering next-generation molecular discovery

AI Protein Folding

Ligand Docking

Nanobody Discovery

Binder Design

Virtual Screening

Mutation Prediction

Discover the Next Generation of Molecular Design

Request Demo Partner With Us

Latest News

Stay updated with CycloGen AI's latest developments and partnerships

Partnership

CycloGen AI Joins the NVIDIA Inception Program

CycloGen AI has been accepted into the NVIDIA Inception Program, an initiative designed to support cutting-edge startups advancing AI and high-performance computing.

Through this program, CycloGen AI gains access to NVIDIA's deep learning resources, technical guidance, and global ecosystem. This collaboration will further accelerate the development of CycloGen AI's GPU-powered molecular discovery platform for protein design, peptide engineering, and small-molecule drug discovery.

Collaboration

CycloGen AI Selected to Beta Test New AI Models from Google

CycloGen AI has been invited by Google to participate in early beta testing of upcoming AI models and developer technologies.

This collaboration enables CycloGen AI to explore advanced AI capabilities for molecular reasoning, biological data analysis, and scientific knowledge extraction. These capabilities will further enhance CycloGen AI's intelligent discovery engine for accelerating therapeutic design.

Research

Global Research Pilots with Universities in North America, Asia and EMEA

CycloGen AI is currently conducting pilot research collaborations with academic institutions across North America, Asia, and the EMEA region (Europe, Middle East, and Africa).

These collaborations focus on applying CycloGen AI's platform to:

  • Protein structure analysis
  • AI-driven therapeutic design
  • Peptide and minibinder discovery
  • Rapid screening of drug candidates

The pilot programs are helping validate CycloGen AI's platform in real-world research environments while expanding partnerships with leading global research universities.

Experience CycloGen AI

Join leading biotech companies accelerating their drug discovery pipeline

Or contact us directly at sales@cyclogen.ai

Partner With Us

We collaborate with pioneering biotech, pharmaceutical, and academic teams to tackle the most challenging problems in drug discovery.

Whether you're exploring a new target, accelerating lead discovery, or validating complex molecular hypotheses, CycloGen AI provides a unified, AI-driven platform to move faster with confidence.

Reach out to explore how we can accelerate your research.